Status:
COMPLETED
Pain After Endoscopic Submucosal Dissection
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Gastric Neoplasm
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Endoscopic submucosal dissection (ESD) is widely used for local treatment of gastric neoplasms. Although ESD-related complications such as bleeding and perforation have been reported, data is currentl...
Detailed Description
A prospective randomized controlled study was conducted evaluating 156 patients with gastric neoplasms treated by ESD at Gangnam Severance Hospital between April 2011 and December 2014. All subjects w...
Eligibility Criteria
Inclusion
- patients undergoing ESD for gastric neoplasms
Exclusion
- (1) history of acid suppressive medication within 1 week prior to the procedure; (2) known gastrointestinal disorders, such as peptic ulcer disease, which might impact epigastric pain assessment; (3) current or regular use of pain medication; (4) history of upper gastrointestinal surgery; (5) multiple lesions requiring ESD; (6) perforation during ESD; and (7) significant cardiovascular, renal, hepatic, neurotic, or psychological disorders
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT02254889
Start Date
April 1 2011
End Date
December 1 2014
Last Update
February 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Da Hyun Jung
Seoul, South Korea, 120-752